A new study suggests that 3-feet social distancing is sufficient for in-person instruction in public schools; Amazon announces it will offer its Amazon Care telemedicine program to private employers nationwide; ACIST Kodama Intravascular Ultrasound Catheter recalled.
Reported by The New York Times, a new study published in the Journal of Clinical Infectious Diseases suggests that in-person instruction for public schools is safe as long as children maintain 3 feet of social distancing, as opposed to the 6-feet rule, along with other preventive measures such as wearing masks. This comes amid reports that President Joe Biden will spend $10 billion in American Rescue Plan funds to states and some cities to screen school children for COVID-19 in an effort to reopen schools in the final months of the school year. The CDC will provide technical assistance to schools to set up and integrate the screening programs.
Amazon announced it will offer its Amazon Care telemedicine program to employers across the country, marking its first nationwide campaign in providing health care services. Reported by ABC News, the Amazon Care app works to connect users virtually with doctors, nurse practitioners, and nurses who can provide care over the phone 24 hours a day. Currently available to the company’s employees in Washington state, Amazon said it will expand the service to all its workers and to interested private employers by this summer.
ACIST Medical Systems announced it is recalling its ACIST Kodama Intravascular Ultrasound Catheter amid reports that the O-ring housing tube may squeeze and damage the O-ring, causing pieces of the O-ring to break free and flush into the patient’s artery during use. Identified by the FDA as a Class 1 recall, the most serious type of recall, the damaged O-ring was noted to potentially cause significant patient harm, including vessel blockage, heart attack, heart arrhythmia, or stroke, as well as chest pain or discomfort.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512